Molecular Partners Ag (MOLN) Other Working Capital Changes (2021 - 2026)

Molecular Partners Ag (MOLN) posted quarterly Other Working Capital Changes of $286.05 for Q1 2026, down 52.9% year-on-year from $607.29 in Q1 2025, and down 99.93% on a QoQ basis from $418978.0 in Q4 2025.

Molecular Partners Ag (MOLN) Other Working Capital Changes (2021 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Other Working Capital Changes for 6 consecutive years, with $286.05 the latest figure, recorded in Q1 2026.

  • Quarterly Other Working Capital Changes fell 52.9% year-over-year to $286.05 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $416066.2 (up 55.53% YoY) and the FY2025 annual result came in at $419141.9, up 54.93% from the prior year.
  • Other Working Capital Changes slipped to -$383.1 in Q1 2026 per MOLN's latest filing, from $757676.4 in the prior quarter.
  • Over the last five years, Other Working Capital Changes for MOLN reached as high as $757676.4 in Q3 2025 and fell as low as -$732823.4 in Q2 2025.
  • A 5-year average of $4662.9 and a median of -$337.01 in 2025 frame the typical range for Other Working Capital Changes.
  • The largest YoY upside for Other Working Capital Changes was 138.51% in 2022 against a maximum downside of 113.48% in 2022.
  • Year by year, Other Working Capital Changes stood at $613103.2 in 2022, then increased by 10.26% to $676010.6 in 2023, then climbed by 2.8% to $694942.4 in 2024, then gained by 9.03% to $757676.4 in 2025, then slumped by 100.05% to -$383.1 in 2026.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered -$383.1, $757676.4, and -$732823.4 for Q1 2026, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,921.77 Bn 66,921.49 Bn -
2 Nanobiotix 1,933.35 Bn 1,933.29 Bn -
3 Akari Therapeutics 1,063.56 Bn 1,063.56 Bn -
4 BeOne Medicines 468.54 Bn 463.75 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.45 Bn 116.20 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.42 Bn 61.67 Bn 3.31 Bn
7 Belite Bio 63.57 Bn 63.57 Bn -
8 Argenx Se 55.83 Bn 50.65 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.75 Bn 34.74 Bn 959.66 Mn
10 Molecular Partners Ag 149.27 Mn 149.27 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -383.10
Mar 31, 2026 -383.10
Mar 31, 2026 -383.10
Sep 30, 2025 757,676.38
Sep 30, 2025 757,676.38
Sep 30, 2025 757,676.38
Jun 30, 2025 -732,823.38
Jun 30, 2025 -732,823.38
Jun 30, 2025 -732,823.38
Mar 31, 2025 -337.01
Mar 31, 2025 -337.01
Mar 31, 2025 -337.01
Sep 30, 2024 694,942.41
Sep 30, 2024 694,942.41
Sep 30, 2024 694,942.41
Jun 30, 2024 -666,460.63
Jun 30, 2024 -666,460.63
Jun 30, 2024 -666,460.63
Mar 31, 2024 -344.85
Mar 31, 2024 -344.85